title: ZEPHYR illustrates the perils of testing targeted treatments in unselected non-small-cell lung cancer patients.
authors: Cleveland Clinic Taussig Cancer Institute, United States.
authors: Rakesh
authors: R
authors: Bagai
authors: Cleveland Clinic Taussig Cancer Institute, United States.
authors: Nathan A
authors: NA
authors: Pennell